30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective

被引：47

作者：

Sharma, Amit ^{[1
,2
]}

Schmidt-Wolf, Ingo G. H. ^{[1
]}

机构：

[1] Univ Hosp Bonn, Ctr Integrated Oncol CIO, Dept Integrated Oncol, D-53127 Bonn, Germany

[2] Univ Hosp Bonn, Dept Neurosurg, D-53127 Bonn, Germany

来源：

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | 2021年 / 40卷 / 01期

关键词：

Cytokine-induced killer (CIK) cell therapy; Immunotherapies; INDUCED KILLER-CELLS;

D O I：

10.1186/s13046-021-02184-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Emerging evidence from the numerous clinical trials involving cytokine-induced killer (CIK) cell therapy suggests that its optimization in combination with other contemporary cancer therapies in a complementary manner (rather than as competition) will be a key to combat cancer.

引用

页数：3

共 10 条

[1] Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells [J].

Cappuzzello, Elisa ;

Sommaggio, Roberta ;

Zanovello, Paola ;

Rosato, Antonio .

CYTOKINE & GROWTH FACTOR REVIEWS, 2017, 36 :99-105

[2] Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells [J].

Dalla Pieta, Anna ;

Cappuzzello, Elisa ;

Palmerini, Pierangela ;

Ventura, Annavera ;

Visentin, Andrea ;

Astori, Giuseppe ;

Chieregato, Katia ;

Mozzo, Valentina ;

Perbellini, Omar ;

Tisi, Maria Chiara ;

Trentin, Livio ;

Visco, Carlo ;

Ruggeri, Marco ;

Sommaggio, Roberta ;

Rosato, Antonio .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)

[3] Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy [J].

Gao, Xingchun ;

Mi, Yajing ;

Guo, Na ;

Xu, Hao ;

Xu, Lixian ;

Gou, Xingchun ;

Jin, Weilin .

FRONTIERS IN IMMUNOLOGY, 2017, 8

[4] Innovative Clinical Perspectives for CIK Cells in Cancer Patients [J].

Introna, Martino ;

Correnti, Fabio .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (02)

[5] Cytokine-induced killer cells-assisted tumor-targeting delivery of Her-2 monoclonal antibody-conjugated gold nanostars with NIR photosensitizer for enhanced therapy of cancer [J].

Liang, Shujing ;

Sun, Menglin ;

Lu, Yonglin ;

Shi, Shuo ;

Yang, Yiting ;

Lin, Yun ;

Feng, Chan ;

Liu, Jie ;

Dong, Chunyan .

JOURNAL OF MATERIALS CHEMISTRY B, 2020, 8 (36) :8368-8382

[6] USE OF A SCID MOUSE HUMAN LYMPHOMA MODEL TO EVALUATE CYTOKINE-INDUCED KILLER-CELLS WITH POTENT ANTITUMOR CELL-ACTIVITY [J].

SCHMIDTWOLF, IGH ;

NEGRIN, RS ;

KIEM, HP ;

BLUME, KG ;

WEISSMAN, IL .

JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (01) :139-149

[7] CIK Cells and HDAC Inhibitors in Multiple Myeloma [J].

Stephan, David ;

Weiher, Hans ;

Schmidt-Wolf, Ingo G. H. .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (05)

[8] DC-CIK as a widely applicable cancer immunotherapy [J].

Wang, Shuo ;

Wang, Xiaoli ;

Zhou, Xinna ;

Lyerly, Herbert Kim ;

Morse, Michael A. ;

Ren, Jun .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (06) :601-607

[9] Increase of Antitumoral Effects of Cytokine-Induced Killer Cells by Antibody-Mediated Inhibition of MICA Shedding [J].

Wu, Xiaolong ;

Zhang, Ying ;

Li, Yutao ;

Schmidt-Wolf, Ingo G. H. .

CANCERS, 2020, 12 (07) :1-12

[10] Ten-year update of the international registry on cytokine-induced killer cells in cancer immunotherapy [J].

Zhang, Ying ;

Schmidt-Wolf, Ingo G. H. .

JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (12) :9291-9303

← 1 →